Preoperative coronary angiography before elective TEVAR detected CAD in 44.7% of patients but was not associated with significant differences in in-hospital mortality (2.1% vs. 6.0%, p=0.159).
Cohort (n=177)
Does routine preoperative coronary angiography improve outcomes in patients undergoing elective thoracic endovascular aortic repair?
Routine preoperative coronary angiography in elective TEVAR candidates detects unrecognized CAD but does not significantly improve long-term survival or reduce perioperative events.
Absolute Event Rate: 2.1% vs 6%
p-value: p=0.159
(1) Background: Coronary artery disease (CAD) frequently coexists with thoracic aortic disease and may increase the risk of adverse outcomes after thoracic endovascular aortic repair (TEVAR). Whether routine preoperative coronary angiography (CAG) improves outcomes remains unclear. (2) Methods: We retrospectively analyzed 177 patients undergoing elective TEVAR between 2015 and 2025 with a median follow-up of 4.9 years. Two analyses were performed: patients who underwent preoperative CAG versus those who did not, and patients with versus without CAD. Survival was assessed using Kaplan–Meier analysis and overlap-weighted Cox regression. (3) Results: Preoperative CAG was performed in 94 patients (53.1%) and identified newly diagnosed or progressive CAD in 42 (44.7%). Overall, 24 patients (13.6%) underwent coronary revascularization before TEVAR. Patients with CAD were older and had a greater comorbidity burden. Despite these differences, preoperative CAG was not associated with differences in in-hospital mortality (2.1% vs. 6.0%, p = 0.159), major adverse cardiovascular events (11.3% vs. 9.0%, p = 0.754), or long-term survival (log-rank p = 0.10). Patients with CAD showed higher unadjusted long-term mortality than those without CAD (31.7% vs. 17.5%; log-rank p = 0.003). However, after overlap weighting, CAD was no longer significantly associated with mortality (adjusted HR 1.4, 95% CI 0.71–2.8). Among patients with angiographically verified coronary disease, preoperative revascularization before TEVAR was not associated with improved long-term survival (HR 2.20, 95% CI 0.69–6.98). (4) Conclusions: Preoperative CAG detects clinically relevant, often unrecognized CAD in a substantial proportion of TEVAR candidates and enables revascularization before surgery. Despite a higher coronary burden, patients who underwent CAG had outcomes comparable to those who did not, and the crude long-term survival disadvantage of CAD was largely explained by the accompanying systemic atherosclerotic burden. Routine preoperative coronary assessment appears justified in elective TEVAR.
Hamiko et al. (Wed,) conducted a cohort in Thoracic aortic disease requiring elective TEVAR (n=177). Preoperative coronary angiography (CAG) vs. No preoperative coronary angiography was evaluated on In-hospital mortality (p=0.159). Preoperative coronary angiography before elective TEVAR detected CAD in 44.7% of patients but was not associated with significant differences in in-hospital mortality (2.1% vs. 6.0%, p=0.159).